Renaissance Technologies - TCR2 THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of TCR2 THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$667
-3.6%
444,800
-35.8%
0.00%0.0%
Q4 2022$692
-99.9%
693,286
-1.9%
0.00%
-50.0%
Q3 2022$1,272,000
-41.6%
706,900
-5.9%
0.00%
-33.3%
Q2 2022$2,179,000
-45.3%
751,300
-47.9%
0.00%
-40.0%
Q1 2022$3,982,000
-4.2%
1,442,600
+61.7%
0.01%0.0%
Q4 2021$4,156,000
+152.0%
891,900
+360.2%
0.01%
+150.0%
Q3 2021$1,649,000
-37.8%
193,800
+20.1%
0.00%
-33.3%
Q2 2021$2,649,000
-19.2%
161,400
+8.7%
0.00%
-25.0%
Q1 2021$3,279,000
+138.3%
148,500
+119.4%
0.00%
+300.0%
Q3 2020$1,376,000
+162.6%
67,700
+98.5%
0.00%
Q2 2020$524,000
+32.0%
34,100
-33.5%
0.00%
Q1 2020$397,00051,3000.00%
Other shareholders
TCR2 THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,050,865$4,046,8141.69%
MPM BioImpact LLC 3,370,982$3,367,6110.87%
TANG CAPITAL MANAGEMENT LLC 2,738,947$2,735,6600.40%
Newtyn Management, LLC 1,075,000$1,073,7100.22%
HARBOR CAPITAL ADVISORS, INC. 68,230$68,1480.07%
Artal Group S.A. 750,000$7490.04%
Oasis Management Co Ltd. 200,000$199,7600.04%
Redmile Group, LLC 731,379$730,5010.03%
X-Square Capital, LLC 31,919$320.02%
CORNERCAP INVESTMENT COUNSEL INC 68,035$67,9530.01%
View complete list of TCR2 THERAPEUTICS INC shareholders